Our Services
Medical Information
Helpful Resources
Published on: 9/13/2026
Jardiance (empagliflozin) is an SGLT2 inhibitor that stops your kidneys from reabsorbing glucose, so excess sugar and the water pulled along with it leave the body as urine, which explains the frequent urination, increased thirst, and mild dehydration many people notice in the first weeks. That same sugar-rich, moist environment around the genitals feeds Candida and bacteria, making yeast infections, balanitis, and urinary tract infections more likely, especially in women, uncircumcised men, and anyone with a history of thrush. Several factors influence how strong these effects are, including your dose, blood sugar control, fluid intake, other medications like diuretics, and rare but serious risks such as ketoacidosis or genital infections that spread; see below to understand more, including which symptoms mean you should stop and call your doctor rather than wait it out.
Because normal medication side effects and early signs of a serious infection can feel almost identical at first, it is worth checking your specific pattern of symptoms instead of guessing. Take a free, instant, online symptom check to see what your urination changes, itching, or discharge could point to and to get clear guidance on whether this can be managed at home or needs prompt medical attention.
Last reviewed for medical accuracy: 09/13/2026
Why Does Jardiance Make Me Pee So Much and Get Yeast Infections?
Keyword: jardiance side effects
Empagliflozin (brand name Jardiance) is in a class of medications called SGLT2 inhibitors. It’s prescribed to help lower blood sugar in people with type 2 diabetes and to reduce the risk of cardiovascular death. While it can be highly effective, two of the most common jardiance side effects are frequent urination and yeast infections. Here’s why they happen and what you can do about them.
Jardiance targets the sodium-glucose co-transporter 2 (SGLT2) proteins in your kidneys. These proteins normally:
When you take Jardiance:
Result: Lower blood sugar—but also more sugar in your urine.
The extra sugar in your urine pulls water with it by a process called osmotic diuresis. This leads to:
Urinating more can lead to:
Tips to manage frequent urination:
Candida (a type of yeast) thrives in warm, moist environments where sugar is present. With higher sugar levels in your urine:
Preventive Measures:
While frequent urination and yeast infections are among the most common, Jardiance can cause other side effects. Most are mild, but some warrant immediate medical attention.
If you experience any of these, speak to a doctor right away.
Stay Hydrated
Monitor Your Blood Pressure
Watch for Infection Signs
Practice Good Hygiene
Keep a Symptom Diary
Even with the best self-care, you may need professional input if you experience:
For non-urgent concerns or to check symptoms quickly, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It’s a convenient way to get guidance on whether you should adjust self-care or seek medical attention.
Jardiance has proven benefits:
But like any medication, it involves weighing benefits against jardiance side effects:
A good partnership with your healthcare provider—and open communication about what you’re experiencing—ensures you get the maximum benefit with the best possible safety.
Final Reminder: Always discuss new or worsening symptoms with a healthcare professional. If you experience severe or life-threatening issues, such as signs of ketoacidosis, acute kidney injury, or uncontrolled infections, please speak to a doctor immediately.
(References)
* Kalra B, Kalra S. Vulvovaginitis and diabetes. J Pak Med Assoc. 2017 Jan;67(1):143-145. PMID: 28065975.
* Verma S, McMurray JJV. SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review. Diabetologia. 2018 Oct;61(10):2108-2117. doi: 10.1007/s00125-018-4670-7. Epub 2018 Aug 22. PMID: 30132036.
* Refardt J, Imber C, Sailer CO, Jeanloz N, Potasso L, Kutz A, Widmer A, Urwyler SA, Ebrahimi F, Vogt DR, Winzeler B, Christ-Crain M. A Randomized Trial of Empagliflozin to Increase Plasma Sodium Levels in Patients with the Syndrome of Inappropriate Antidiuresis. J Am Soc Nephrol. 2020 Mar;31(3):615-624. doi: 10.1681/ASN.2019090944. Epub 2020 Feb 4. PMID: 32019783; PMCID: PMC7062212.
* Lopaschuk GD, Verma S. Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: A State-of-the-Art Review. JACC Basic Transl Sci. 2020 Jun;5(6):632-644. doi: 10.1016/j.jacbts.2020.02.004. Epub 2020 Jun 22. PMID: 32613148; PMCID: PMC7315190.
* Salvatore T, Galiero R, Caturano A, Rinaldi L, Di Martino A, Albanese G, Di Salvo J, Epifani R, Marfella R, Docimo G, Lettieri M, Sardu C, Sasso FC. An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors. Int J Mol Sci. 2022 Mar 26;23(7). doi: 10.3390/ijms23073651. Epub 2022 Mar 26. PMID: 35409011; PMCID: PMC8998569.
* Refardt J, Imber C, Nobbenhuis R, Sailer CO, Haslbauer A, Monnerat S, Bathelt C, Vogt DR, Berres M, Winzeler B, Bridenbaugh SA, Christ-Crain M. Treatment Effect of the SGLT2 Inhibitor Empagliflozin on Chronic Syndrome of Inappropriate Antidiuresis: Results of a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial. J Am Soc Nephrol. 2023 Feb 1;34(2):322-332. doi: 10.1681/ASN.2022050623. Epub 2022 Nov 17. PMID: 36396331; PMCID: PMC10103093.
* Carvalho PEP, Veiga TMA, Simões E Silva AC, Gewehr DM, Dagostin CS, Fernandes A, Nasi G, Cardoso R. Cardiovascular and renal effects of SGLT2 inhibitor initiation in acute heart failure: a meta-analysis of randomized controlled trials. Clin Res Cardiol. 2023 Aug;112(8):1044-1055. doi: 10.1007/s00392-022-02148-2. Epub 2023 Jan 2. PMID: 36592186; PMCID: PMC9807098.
* Vallon V. State-of-the-Art-Review: Mechanisms of Action of SGLT2 Inhibitors and Clinical Implications. Am J Hypertens. 2024 Oct 14;37(11):841-852. doi: 10.1093/ajh/hpae092. PMID: 39017631; PMCID: PMC11471837.
* Behrend EN, Ward CR, Chukwu V, Cook AK, Kroh C, Lathan P, May J, Schermerhorn T, Scott-Moncrieff JC, Voth R. Velagliflozin, a once-daily, liquid, oral SGLT2 inhibitor, is effective as a stand-alone therapy for feline diabetes mellitus: the SENSATION study. J Am Vet Med Assoc. 2024 Oct 1;262(10):1343-1353. doi: 10.2460/javma.24.03.0174. Epub 2024 Aug 14. PMID: 39142336.
* Veauthier B, Levy-Grau B. Diabetic Ketoacidosis: Evaluation and Treatment. Am Fam Physician. 2024 Nov;110(5):476-486. PMID: 39556629.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.